학술논문

Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia
Document Type
Article
Source
In: Cancers. (Cancers, May 2023, 15(10))
Subject
Language
English
ISSN
20726694